Significance
efficacy. An area of focus has been on identifying ways by which to improve upon 30 RV144 vaccine-efficacy. The RV305 HIV-1 vaccine-regimen was a follow-up boost of 31 RV144 vaccine-recipients that occurred 6-8 years after the conclusion of RV144. Our
32

INTRODUCTION
50
CD4-inducible (CD4i) epitopes within HIV-1 envelope (Env) constant regions 1 and 51 2 (C1C2) are targets for antibodies that mediate antibody dependent cellular cytotoxicity 52 (ADCC) [1] . C1C2-specific antibody epitopes have been termed Cluster A [1] and defined 53 by two Env-targeted monoclonal antibodies (mAbs), A32 [2] and C11 [1] . Structural 54 analyses of antigen complexes formed by A32, A32-like [3] [4] [5] and C11-like antibodies [6] 55 the gp120 N-terminal 11 amino acids [10] . To determine if C11 could bind to gp120 79 proteins with an 11 amino acid N-terminal deletion, we assayed A32 and C11 antibodies 80 for binding to full length AE.A244gp120 or to AE.A244gp120Δ11 (N-terminal 11 aa 81 deleted). Antibody A32 bound to full length AE.A244gp120 and A32 binding was 82 enhanced on AE.A244gp120Δ11 (Fig. 1A) [9] . In contrast, antibody C11 only bound to 83 the full length AE.A244gp120 (Fig 1A) . From these data we concluded that C11-like 84 antibody responses were unlikely to be boosted by AIDSVAX B/E.
85
A total of 19 RV305-derived NNAbs isolated from four individuals ( (Wilcoxon rank sum test P < 0.0001) (Fig 1C) suggesting that RV305 boosting induced 90 additional somatic mutations in C1C2-specific antibodies.
91
To determine if RV305 boosted A32 blockable antibodies contained a binding 92 epitope similar to A32, we used the A32 ligand crystal structure [5] to identify critical 93 A32 antibody contact residues, and then designed an AE.A244gp120Δ11 mutant 94 protein (AE.A244gp120Δ11 F35S, H72L, V75A, E106K, D107H, S110A, Q114L) to 95 eliminate A32-like antibody binding (Fig 1A) . In ELISA, the RV305 antibody, DH838, 96 was the only antibody with binding eliminated by mutating the A32 epitope (Fig 1D) . 97 Likewise, DH838 was the only antibody that used a VH3 family gene while all other 98 ALVAC/AIDSVAX B/E -induced C1C2-specific antibodies used VH1 genes (Table S1) . 99 Thus, as in RV144, ALVAC/AIDSVAX B/E boosting preferentially expanded VH1 gene 100 C1C2-specific antibodies [11] and these antibodies bound epitopes distinct from A32 101 but in close enough proximity to be sterically cross-blocked by A32 (Fig 1B) .
102
Boosting increased C1C2-specific ADCC breadth and potency. RV305 Table 1) . Next RV305 derived C1C2-specific antibody heavy chain gene 111 mutation frequency was used as a proxy for responsiveness to boosting and compared 112 to the ADCC score. The VH mutation frequency (% nucleotide) inversely correlated with 113 the ADCC score (Spearman Correlation -0.5599; p value = 0.0127) (Fig S1) . However 114 the VH mutation frequency of those antibodies with the highest ADCC scores were 115 above the average heavy chain gene mutation frequency for RV144 (Fig S1 Fig 1C) .
116
Thus, while a RV144 boosting regimen was necessary to increase C1C2-specific ADCC 117 breadth and potency, additional boosting with same immunogens may not be beneficial. was enhanced with AE.A244gp120Δ11 (Fig 2 and Fig S2) improved binding to full length AE.A244gp120 (Fig 2 and Fig S2) .
137
The ontogeny of vaccine-induced ADCC was studied by assaying the DH677 (Fig 2 and Fig S3) . These data indicated that the RV144 prime-boost 144 regimen was insufficient to fully affinity mature this C1C2-specific B cell clonal lineage. Table S4 ). The majority of contacts providing specificity involve 159 a network of hydrogen bonds and a salt bridge (Fig 3A, inset) contributed by the antibody 160 heavy chain and gp120 side chain atoms of layer 1 (α turn connecting the ͞ 1--β0 strands,
161
D 78 and N 80 ) and the 7-stranded-β-sandwich (strand β7, Q 246 ). The contacts provided by 162 the light chain are less specific and consist of hydrogen bonds to the gp120 main chain 163 atoms and hydrophobic contacts within a hydrophobic cleft formed at the layer 1/2/β-164 sandwich junction (Fig 3B and C) strand is involved in binding was not possible (Fig 3) . However, we were able to model 189 the N/C-termini-gp12093TH057 coree from the N12-i3 Fab complex structure (PDB code: 190 5W4L) to the DH677.3 Fab-gp12093TH057 coree-M48U1 complex without any steric 191 clashes (Fig 4A, inset) inner domain Layer 1 and the 7-stranded-β-sandwich (Fig 3 and 4) with 10 μg/mL of each mAb. Co-cultures were incubated for 6 h at 37 C in 5% CO2. grown from 20% PEG 3000, 100 mM HEPES pH 7.5, and 200 mM sodium chloride.
491
DH677.3 complex crystals were grown from 25% PEG 4000 and 100 mM MES pH 5.5.
492
Crystals were briefly soaked in crystallization solution plus 20% MPD before being flash 493 frozen in liquid nitrogen prior to data collection. Wilcoxon rank sum test. Statistical analysis was performed using SAS software (SAS
520
Institute Inc., Cary, N.C.). chain gene sequence mutation frequencies were analyzed by Cloanalyst (Kepler et al., 531 2014) and compared to previously published RV144 heavy and light chain gene 532 sequence mutation frequencies (% nucleotide) (Bonsignori et al., 2012 Figure 1 with the A32 and N12-i2 epitope footprints shown in black. In (C) the DH677.3,
585
A32 and N12-i3 gp120 contact residues are mapped onto the gp120 sequence. Side 586 chain (+) and main chain (-) contact residues are colored green for hydrophobic, blue for 587 hydrophilic and black for both as determined by a 5 Å cut off value over the 588 corresponding sequence. Buried surface residues as determined by PISA are shaded.
589
The DH677.3 epitope footprint overlays with the epitopes of both A32 and N12-i3. as in Figure 1 and buried surface residues as determined by PISA are shaded. 
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